StonvexLoading…
StonvexStonvexStonvexCore line items from BUKS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Annual 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $70.29M | $43.38M | $20.13M | $83.97M |
Operating Income | $20.98M | $11.74M | $4.67M | $16.83M |
Net Income | $16.38M | $5.99M | $3.69M | $12.55M |
EPS (Diluted) | $0.25 | $0.15 | $0.06 | $0.19 |
Total Assets | $140.98M | $128.18M | $130.28M | $123.30M |
Total Liabilities | $64.64M | $57.97M | $65.04M | $58.18M |
Cash & Equivalents | $36.49M | $29.64M | $33.44M | $25.23M |
Free Cash Flow OCF − CapEx | $19.77M | $10.59M | $13.26M | $10.14M |
Shares Outstanding | 64.07M | 64.28M | 64.85M | 67.18M |